108 related articles for article (PubMed ID: 2538905)
21. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens].
Winkler UH; Krämer R; Kwee B; Schindler AE
Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837
[TBL] [Abstract][Full Text] [Related]
22. [Transdermal and oral hormone substitution with estrogens: a comparison].
Schindler AE
Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
[TBL] [Abstract][Full Text] [Related]
23. [Hormone substitution treatment of the menopause].
González-Merlo J; Castelo-Branco C; Celades M
Rev Med Univ Navarra; 1992; 37(3):143-51. PubMed ID: 1336213
[No Abstract] [Full Text] [Related]
24. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us?
Sherwin BB
Ann N Y Acad Sci; 2005 Jun; 1052():3-10. PubMed ID: 16024746
[TBL] [Abstract][Full Text] [Related]
25. Type-IV hypersensitivity to topical estradiol in a patient tolerant to it orally.
Boehncke WH; Gall H
Contact Dermatitis; 1996 Sep; 35(3):187-8. PubMed ID: 8930492
[No Abstract] [Full Text] [Related]
26. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Price TM; Blauer KL; Hansen M; Stanczyk F; Lobo R; Bates GW
Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
[TBL] [Abstract][Full Text] [Related]
27. [Conjugated estrogens, estrogen excretion and antigonadotropic effect].
Laschet U; Laschet L
Arzneimittelforschung; 1970 Apr; 20(4):542-5. PubMed ID: 4315906
[No Abstract] [Full Text] [Related]
28. [Estrogen treatment of women after the menopause].
Furuhjelm M
Lakartidningen; 1974 Feb; 71(7):605-7. PubMed ID: 4365587
[No Abstract] [Full Text] [Related]
29. [Management of the climacteric syndrome exemplified by ambulatory care of menopause at the 1st University Gynecologic Clinic].
Metka M
Gynakol Rundsch; 1987; 27(4):252-6. PubMed ID: 2830178
[No Abstract] [Full Text] [Related]
30. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
Sajtos B; Herold J; Winkler UH; Schindler AE
Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
[TBL] [Abstract][Full Text] [Related]
31. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
Kroon UB; Silfverstolpe G; Tengborn L
Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
[TBL] [Abstract][Full Text] [Related]
32. Oestrogens and post-menopausal osteoporosis.
Linde J; Friis T; Ostergaard E
Calcif Tissue Res; 1976 Aug; 21 Suppl():478-83. PubMed ID: 953839
[No Abstract] [Full Text] [Related]
33. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
[TBL] [Abstract][Full Text] [Related]
34. Effect of transdermal estradiol and oral conjugated equine estrogen on C-reactive protein in retinoid-placebo trial in healthy women.
Wakatsuki A; Okatani Y; Fukaya T
Circulation; 2003 May; 107(18):e127-8; author reply e127-8. PubMed ID: 12742976
[No Abstract] [Full Text] [Related]
35. Biologic effects of various doses of ethinyl estradiol in postmenopausal women.
Mandel FP; Geola FL; Lu JK; Eggena P; Sambhi MP; Hershman JM; Judd HL
Obstet Gynecol; 1982 Jun; 59(6):673-9. PubMed ID: 6281707
[TBL] [Abstract][Full Text] [Related]
36. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
Pinkerton JV; Pickar JH; Racketa J; Mirkin S
Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
[TBL] [Abstract][Full Text] [Related]
37. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
Ettinger B; Pressman A; Bradley C
Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
[TBL] [Abstract][Full Text] [Related]
38. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
[TBL] [Abstract][Full Text] [Related]
39. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women.
Mandel FP; Geola FL; Meldrum DR; Lu JH; Eggena P; Sambhi MP; Hershman JM; Judd HL
J Clin Endocrinol Metab; 1983 Jul; 57(1):133-9. PubMed ID: 6304131
[TBL] [Abstract][Full Text] [Related]
40. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
